⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRMD News
CorMedix Inc.
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
CRMD
CorMedix Therapeutics Announces Leadership and Board Updates
globenewswire.com
CRMD
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates
globenewswire.com
CRMD
CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath
globenewswire.com
CRMD
CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance
globenewswire.com
CRMD
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025
globenewswire.com
CRMD
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
globenewswire.com
CRMD
CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO
globenewswire.com
CRMD
Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market
prnewswire.com
TLPH
CRMD